Trial Profile
Phase 1/2 Study of the Effect of TOT or Solifenacin After Cesa or Vasa on Urge Urinary Incontinence
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Dec 2019
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Mixed incontinence; Urge incontinence
- Focus Therapeutic Use
- Acronyms URGE-II
- 31 Aug 2018 Status changed from recruiting to completed, according to results presented at the 48th Annual Meeting of the International Continence Society.
- 31 Aug 2018 Results presented at the 48th Annual Meeting of the International Continence Society
- 07 Jan 2013 New trial record